Abstract
Recently Brazilian laws were created to protect medicinal plants and regulate their uses. Representatives of Myrcia (Myrtaceae) are widely distributed in Brazil and known for their pharmacological potential. However, the only work to compile information on medicinal species of the genus refers to savanna plants. Aiming to obtain a complete overview of the subject, we conducted a wide search, finding 52 publications mentioning 37 scientific names and 26 popular names. After investigating synonyms, we obtained 28 species from five geographic regions and six phytogeographic domains. Most species are arboreal, but five (M. guianensis, M. hirtiflora, M. magnoliifolia, M. palustris and M. selloi) can also have a shrubby habit, and one (M. guianensis) can also be represented by subshrubs. The most used part is the leaf. In the compilation, 15 pharmacological properties were listed, and the antioxidant property stood out the most, appearing 16 times in the table. The development of new research, focused on the efficacy of pharmacological activities is necessary, since some of the species mentioned in the consulted works do not have any type of work of this nature. In addition, awareness should be spread about the importance of its correct and responsible use as an herbal resource.
Publisher
Fiocruz - Instituto de Tecnologia em Farmacos
Reference88 articles.
1. Maciel MAM, Pinto AC, Veiga Junior VF, Grynberg NF. Plantas medicinais: a necessidade de estudos multidisciplinares. Quím Nova. Maio 2002; 25(3): 429-438. [https://doi.org/10.1590/S0100-40422002000300016].
2. Veiga Junior VF, Pinto AC, Maciel MAM. Plantas medicinais: cura segura? Quím Nova. Jun 2005; 28(3): 519-528. [https://doi.org/10.1590/S0100-40422005000300026].
3. Brasil. Ministério da Saúde. Glossário temático: práticas integrativas e complementares em saúde. 1a ed. Brasília - DF. 2018. [https://aps.saude.gov.br/biblioteca/visualizar/MTM0Ng==].
4. Bezerra DG, Arruda NA, Borges PP, Ferreira RB, D’Abadia PL, Neto CMS et al. Percepção sobre o uso de plantas medicinais e impactos no Cerrado na região da Cidade de Goiás (GO). RevBEA Ago 2020; 15(5): 391-408. [https://doi.org/10.34024/revbea.2020.v15.10417].
5. Brasil. Ministério da Saúde. Política e Programa Nacional de Plantas Medicinais e Fitoterápicos / Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Assistência Farmacêutica. Brasília: Ministério da Saúde 2016. [https://bvsms.saude.gov.br/bvs/publicacoes/politica_programa_nacional_plantas_medicinais_fitoterapicos.pdf].